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Abstract
The 2013–2016 epidemic of Ebola virus disease was of unprecedented magnitude, duration and 
impact. Analysing 1610 Ebola virus genomes, representing over 5% of known cases, we 
reconstruct the dispersal, proliferation and decline of Ebola virus throughout the region. We test 
the association of geography, climate and demography with viral movement among administrative 
regions, inferring a classic ‘gravity’ model, with intense dispersal between larger and closer 
populations. Despite attenuation of international dispersal after border closures, cross-border 
transmission had already set the seeds for an international epidemic, rendering these measures 
ineffective in curbing the epidemic. We address why the epidemic did not spread into 
neighbouring countries, showing they were susceptible to significant outbreaks but at lower risk of 
introductions. Finally, we reveal this large epidemic to be a heterogeneous and spatially 
dissociated collection of transmission clusters of varying size, duration and connectivity. These 
insights will help inform interventions in future epidemics.
At least 28,646 cases and 11,323 deaths1 have been attributed to the Makona variant of 
Ebola virus (EBOV)2 in the two and a half years it circulated in West Africa. The epidemic 
is thought to have begun in December 2013 in Guinea, but was not detected and reported 
until March 20143. Initial efforts to control the outbreak in Guinea were considered to be 
succeeding4, but in early 2014 the virus crossed international borders into neighbouring 
Liberia (first cases diagnosed in late March) and Sierra Leone (first documented case in late 
February5, 6, first diagnosed cases in May7). EBOV genomes sequenced from three patients 
in Guinea early in the epidemic3 demonstrated that the progenitor of the Makona variant 
originated in Middle Africa and arrived in West Africa within the last 15 years7, 8. Rapid 
sequencing from the first reported cases in Sierra Leone confirmed that EBOV had crossed 
the border from Guinea and were not the result of an independent zoonotic introduction7. 
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Subsequent studies analysed the genetic makeup of the Makona variant, focusing on 
Guinea9–11, Sierra Leone12, 13 or Liberia14, 15, identifying local viral lineages and 
transmission patterns within each country.
Although virus sequencing has covered considerable fractions of the epidemic in each 
affected country, individual studies focused on either limited geographical areas or time 
periods, so that the regional level patterns and drivers of the epidemic across its entire 
duration have remained uncertain. Using 1610 genome sequences collected throughout the 
epidemic, representing over 5% of recorded Ebola virus disease (EVD) cases (Figure 1), we 
reconstruct a detailed phylogenetic history of the movement of EBOV within and between 
the three most affected countries. Using a recently developed phylogeographic approach that 
integrates covariates of spatial spread16, we test which features of each region 
(administrative, economic, climatic, infrastructural and demographic) were important in 
shaping the spatial dynamics of EVD. We also examine the effectiveness of international 
border closures on controlling virus dissemination. Finally, we investigate why regions that 
immediately border the most affected countries did not develop protracted outbreaks similar 
to those that ravaged Sierra Leone, Guinea and Liberia.
Origin, ignition and trajectory of the epidemic
Molecular clock dating indicates that the most recent common ancestor of the epidemic 
existed between December 2013 and February 2014 (mean 2014.06, 95% credible interval, 
CI: 2013.96, 2014.14) and phylogeographic estimation assigns this ancestor to the 
Guéckédou Prefecture, Nzérékoré Region, Guinea, with high credibility (Figure 2). In 
addition, we find that initial EBOV lineages deriving from this common ancestor circulated 
among Guéckédou Prefecture and its neighbouring prefectures of Macenta and Kissidougou 
until late February 2014 (Figure 2). These results support the epidemiological evidence that 
the West African epidemic began in late 2013 in Guéckédou Prefecture3.
The first EBOV introduction from Guinea into another country that resulted in sustained 
transmission is estimated to have occurred in early April 2014 (Figure 2), when the virus 
spread to Kailahun District of Sierra Leone5, 6. This lineage was first detected in Kailahun at 
the end of May 2014, from where it spread across the region (Figures 4 & 3). From Kailahun 
EBOV spread extremely rapidly in May 2014 into several counties of Liberia (Lofa, 
Montserrado and Margibi)15 and Guinea (Conakry, back into Guéckédou)9, 11. The virus 
continued spreading westwards through Sierra Leone, and by July 2014 EBOV was present 
in the capital city, Freetown.
By mid-September 2014 Liberia was reporting >500 new EVD cases per week, mostly 
driven by a large outbreak in Montserrado County, which encompasses the capital city, 
Monrovia. Sierra Leone reported >700 new cases per week by mid-November, with large 
outbreaks in Port Loko, Western Urban (Freetown) and Western Rural districts (Freetown 
suburbs). December 2014 brought the first signs that efforts to control the epidemic in Sierra 
Leone were effective as EVD incidence began dropping. By March 2015 the epidemic was 
largely under control in Liberia and eastern Guinea, although sustained transmission 
continued in the border area of western Guinea and western Sierra Leone. By the following 
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month prevalence had declined such that only a handful of lineages persisted10, 12 (Figure 
4).
The last EBOV genome resulting from a conventionally-acquired infection was collected 
and sequenced in October 2015 in Forécariah Prefecture (Guinea)10. After this, only 
sporadic cases of EVD were detected: in Montserrado (Liberia) in November 2015, 
Tonkolili (Sierra Leone) in January and February 2016, and Nzérékoré (Guinea) in March 
2016. All these sporadic cases likely resulted from transmission from EVD survivors with 
established persistent infections12, 17, 18.
Factors associated with EBOV dispersal
To determine the factors that influenced the spread of EBOV among administrative regions 
at the district (Sierra Leone), prefecture (Guinea) and county (Liberia) levels we used a 
phylogeographic generalized linear model (GLM)16. Of the 25 factors assessed (see Table 3 
for a full list and description) five were included in the model with categorical support 
(Table 1). In summary, EBOV tends to disperse between geographically close regions (great 
circle distance: Bayes factor (BF) support for inclusion BF>50). Half of all virus dispersals 
occurred between locations <72 km apart and only 5% involved movement over 232 km 
(Figure 11a). Both origin and destination population sizes are very strongly (BF>50) 
positively correlated with viral dissemination, with a stronger effect for origin population 
size. The positive effect of population sizes combined with the inverse effect of geographic 
distance, implies that the epidemic’s spread followed a classic gravity-model dynamic. 
Gravity models, widely used in economic and geographic studies and a natural choice for 
modelling infectious disease transmission19–21, describe the movement of people between 
locations as a function of their population sizes and distance apart. Here we use viral 
genomes to provide empirical evidence that such a process drove viral dissemination during 
the EVD epidemic.
In addition to geographical distance, we found a significant propensity for virus dispersal to 
occur within each country, relative to internationally (Nat/Int effect, BF>50), suggesting that 
country borders acted to curb the geographic spread of EBOV. When international dispersals 
do take place, they are more intense between administrative regions that are adjacent at an 
international border (IntBoSh, BF>50).
We tested whether sharing of any of 17 vernacular languages explains virus spread, as 
common languages might reflect cultural links including between non-contiguous or 
international regions, but found no evidence that such linguistic links were correlated with 
EBOV spread. A variety of other possible predictors of EBOV transmission, such as aspects 
of urbanization (economic output, population density, travel times to large settlements) and 
climatic effects, were not significantly associated with virus dispersal. However, these 
factors may have contributed to the size and longevity of transmission chains after 
introduction to a region (see below).
Finally, to investigate the potential of ‘real-time’ viral genome sequencing, we considered 
the degree to which the findings could have been obtained at the height of the epidemic, had 
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sequences been available shortly after samples were taken (see Methods for details). For the 
factors associated with EBOV dispersal the results were extremely comparable with those 
for the full dataset with the same five factors being strongly supported and having similar 
effect sizes (Figure 5).
Factors associated with local EBOV proliferation
The analysis above identified predominantly geographical and administrative factors that 
predict the degree of importation risk, i.e. the likelihood that a viral lineage initiates at least 
one infection in a new region. However, the epidemiological consequences of each 
introduction—the size and duration of resulting transmission chains—may be affected by 
different factors. Thus we investigated which demographic, economic and climatic factors 
might predict cumulative case counts1 for each region (Bayesian GLM; see Methods) and 
found these were associated with factors related to urbanization (Table 2): primarily 
population sizes (PopSize, BF 29.6) and a significant inverse association with travel times to 
the nearest settlement with >50,000 inhabitants (tt50K, BF 32.4). These results confirm the 
common perception that, in contrast to previous EVD outbreaks, widespread transmission 
within urban regions in West Africa was a major contributing factor to the scale of the 
epidemic of the Makona variant.
As the epidemic in West Africa progressed there were fears that increased rainfall and 
humidity might prolong environmental persistence of EBOV particles, increasing the 
likelihood of transmission22. Although we found no evidence of an association between 
EBOV dispersal and any aspects of local climate, we find that regions with less seasonal 
variation in temperature, and more rainfall, tended to have larger EVD outbreaks (TempSS, 
BF >50 and Precip, BF 4.4 respectively).
Effect of international travel restrictions on EBOV dispersal
Porous borders between Liberia, Sierra Leone and Guinea may have allowed unimpeded 
EBOV spread during the 2013–2016 epidemic23–25. Our results indicate that international 
borders were associated with a decreased rate of transmission events compared to national 
borders (Figure 6), but that frequent international cross-border transmission events still 
occurred. These events were concentrated in Guéckédou Prefecture (Guinea), Kailahun 
District (Sierra Leone) and Lofa Country (Liberia) during the early phases of the epidemic 
(Figure 7a), and between Forécariah Prefecture (Guinea) and Kambia District (Sierra Leone) 
in the later stage (Figure 7b). These later EBOV movements significantly hindered efforts to 
interrupt the final chains of transmission in late 2015, with EBOV from such chains moving 
back and forth across this border10, 12, 26.
Sierra Leone announced border closures on 11 June 2014, followed by Liberia on 27 July 
2014, and Guinea on 9 August 2014, but little information is available about what these 
border closures actually entailed. Although we show that the relative contribution of 
international spread to overall viral migration was lower after country borders were closed 
(mean Nat/Int coefficient increasing from 1.15 to 2.83 between August and September 2014; 
80.0% posterior support; (Figure 4b), it is difficult to ascertain whether the border closures 
Dudas et al. Page 4
Nature. Author manuscript; available in PMC 2017 December 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
themselves were responsible for the apparent reduction in cross-border transmissions, as 
opposed to concomitant control efforts or public information campaigns. However, even if 
border closures reduced international traffic, particularly over longer distances and between 
larger population centres, by the time Sierra Leone and Liberia closed their borders the 
epidemic had become firmly established in both countries (Figure 4).
Why did the epidemic not spread further?
A few EBOV exportations were documented from Guinea by road transport into Mali and 
Senegal27, 28 and by air from Liberia to Nigeria and USA29, 30. However, apart from these 
limited exceptions, the West African Ebola virus epidemic did not spread into the 
neighbouring regions of Côte d’Ivoire, Guinea-Bissau, Mali, and Senegal. By extending our 
GLM (the supported predictors and their estimated coefficients) to include these regions we 
were able to address whether they were spared EVD cases through good fortune, or because 
they were associated with an inherently lower risk of EBOV spread and transmission. We 
estimated the degree to which these, apparently EVD-free, regions had the potential to be 
exposed to viral introductions from affected regions (see Methods).
Overall, the contiguous regions in unaffected neighbouring countries were all predicted to 
have low numbers of EBOV introductions (Figures 8a and 9a) based on the phylogeographic 
history of the sampled cases. They were not, however, predicted to have particularly low 
levels of transmission if an outbreak had been seeded (Figures 8b and 9b). Thus, it is likely 
that some of these regions were at risk of becoming part of the EVD epidemic, but that their 
geographical distance from areas of active transmission and the attenuating effect of 
international borders prevented this from occurring. The Kati Cercle in Mali and Tonkpi 
Region in Côte d’Ivoire are to some extent exceptions to this general result, being more 
susceptible to EBOV introductions under the gravity model because of their large 
populations (1 million and 950,000, respectively), (Figure 8a) and predicted to have 
experienced many cases had EVD become established (Figure 8b).
Metapopulation structure and dynamics of the EVD epidemic
After the initial establishment of transmission in Sierra Leone and Liberia, Guinea 
experienced repeated reintroductions of viral lineages from disparate transmission chains 
from both countries (Figure 4). Our analysis reveals that there were at least 21 (95% CI: 16 – 
25) re-introductions into Guinea from April 2014 to February 2015. An early epidemic 
lineage was established around the Guinean capital, Conakry, and persisted for the duration 
of the epidemic (GN-1 in Figures 2 & 4). However, the continual ‘seeding’ of EBOV into 
Guinea without a clear peak in transmission suggests that elsewhere the virus may have been 
failing to maintain transmission. There were also numerous introductions into Sierra Leone 
over a similar time period (median: 9, 95% CI: 6 – 12) but the resulting transmission chains 
constituted a tiny proportion of the country’s EVD cases, with the bulk of transmission 
resulting from one early introduction (Figure 4a).
In all three countries, repeated seeding of administrative regions seems to have been a large 
factor in the longevity of the EVD epidemic (Figure 10). As such, regional case numbers 
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were generally the result of multiple overlapping introduction events followed by within-
region spread and occasional onward transmission to other regions. This suggests a 
metapopulation model in which the epidemic’s persistence was driven by introduction into 
novel contact networks rather than by mass-action susceptible-infectious-removed (SIR) 
dynamics31, 32. We found that, on average, EBOV migrates between administrative regions 
at a rate of 0.85 events per lineage per year (95% CI: 0.72, 0.97). Assuming a serial interval 
of 15.3 days33, this rate translates to a 3.6% chance (95% CI: 3.0%, 4.1%) that over the 
course of a single infection, the transmission chain moved between regions. Given the key 
role that virus dispersal played in sustaining the epidemic, the detection and isolation of 
these relatively low proportion of mobile cases may have a disproportionate effect on the 
control of an EVD epidemic.
From our spatial phylogenetic model we conclude that many regions experienced numerous 
independent EBOV introductions (Figure 11b). However, these introductions gave rise to 
clusters of cases that were generally small (a mean cluster size of 4.3 and only 5% larger 
than 17 in our sample; Figure 11c) and of limited duration (a mean persistence time of 41.3 
days with only 5% greater than 181 days; Figure 11d). Here, we define a ‘cluster’ as a group 
of sequenced cases in a region that derive from a single introduction event and define 
‘persistence’ as the time between the introduction event and the last sampled case in the 
cluster. These definitions are conservative regarding sampling intensity as we expect 
additional samples would have split clusters apart rather than join them. Furthermore, 
introductions that were not detected will be disproportionately smaller, and so the cluster 
size estimate will be biased upwards. Segregating these observations by country (Figure 12a) 
shows that districts of Sierra Leone had more introductions and Guinea generally had 
smaller clusters but persistence was similar between the three countries. Considering only 
introductions that occurred before October 2014 to those that occurred after, the number of 
introductions per location was comparable whereas those that occurred early generally 
resulted in larger and more persistent clusters (Figure 12b).
Thus, with 5.8% sampling, we arrive at a conservative estimate of approximately 75 regional 
cases per introduction event. Although larger population centres, in particular capital cities, 
generally experienced more introductions (Figure 13a), the cluster sizes are less strongly 
associated with population size (Figure 13b), further highlighting the role of virus movement 
into urban areas as major factor for the high case loads in large population centres. Frequent 
cluster extinction, despite a small fraction of individuals being infected, suggests that 
individual outbreaks were constrained by the degree of connectedness among contact 
networks. Thus, it appears that the West African EVD epidemic was sustained by frequent 
seeding that resulted in numerous small local clusters of cases, some of which went on to 
seed further local clusters.
Viral genomics as a tool for outbreak response
The 2013–2016 EVD epidemic in West Africa has unfortunately become a costly lesson in 
addressing an infectious disease outbreak in the absence of preparedness of both the exposed 
population and the international community. Our work demonstrates the value of pathogen 
genome sequencing in a public healthcare emergency and the value of timely pre-publication 
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data sharing to identify the origins of imported disease case clusters, to track pathogen 
transmission as the epidemic progresses, and to follow up on individual cases as the 
epidemic subsides.
It is inevitable that as sequencing costs decrease, accuracy increases, and sequencing 
instruments become more portable, real-time viral surveillance and molecular epidemiology 
will be routinely deployed on the front lines of infectious disease outbreaks10, 12, 14, 34–36. 
Although we have shown here that the broad pattern of EBOV spatial movement was 
discernible from virus genomes derived from samples collected only up until October 2014, 
there was a notable hiatus in sequencing at this time35 and the genomes in the present data 
set from that time were sequenced retrospectively from archived material. The West African 
EVD epidemic has demonstrated that a steady sequencing pace34–36, local sequencing 
capacity10, 12, 14 and rapid dissemination of data7 are key ingredients in generating 
actionable sequence data from an infectious disease outbreak. However, as viral genome 
sequencing is scaled up and approaches the time-scale of viral evolution, the analysis 
techniques will increasingly represent the bottleneck for timely communication of 
information for outbreak response.
The analysis of the comprehensive EBOV genome set collected during the 2013–2016 EVD 
epidemic, including the findings presented here and in other studies7, 9, 11–15, 37, 38 provides 
a framework for predicting the behaviour of future disease outbreaks caused by EBOV, other 
filoviruses, and perhaps other human pathogens. However, many open questions remain 
about the biology of EBOV. As sustained human-to-human transmission waned, West Africa 
experienced several instances of recrudescent transmission, often in regions that had not 
seen cases for many months as a result of persistent sub-clinical infections17, 18, 39. 
Although, in hindsight, such sequelae were not entirely unexpected40, the magnitude of the 
2013–2016 epidemic has put the region at ongoing risk of sporadic EVD re-emergence. 
Similarly, the nature of the reservoir of EBOV, and its geographic distribution, remain as 
fundamental gaps in our knowledge. Resolving these questions is critical to predicting the 
risk of zoonotic transmission and hence of future EVD outbreaks.
Methods
Sequence data
We compiled a data set of 1,610 publicly available full Ebola virus (EBOV) genomes 
sampled between 17 March 2014 and 24 October 2015 (see https://github/ebov/space-time/
data/ for full list and metadata). The number of sequences and the proportion of cases 
sequenced varies with country; our data set contains 209 sequences from Liberia (3.8% of 
known and suspected cases), 982 from Sierra Leone (8.0%) and 368 from Guinea (9.2%) 
(Supplementary Table 1). Most (N=1,100) genomes are of high quality, with ambiguous 
sites and gaps comprising less than 1% of total alignment length, followed by sequences 
with between 1% and 2% of sites comprised of ambiguous bases or gaps (N=266), 98 
sequences with 2–5%, 120 sequences with 5–10% and 26 sequences with more than 10% of 
sites that are ambiguous or are gaps. Sequences known to be associated with sexual 
transmission or latent infections were excluded, as these viruses often exhibit anomalous 
molecular clock signals17, 18. Sequences were aligned using MAFFT41 and edited manually. 
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The alignment was partitioned into coding regions and non-coding intergenic regions with a 
final alignment length of 18,992 nucleotides (available from https://github/ebov/space-time/
data/).
Masking putative ADAR edited sites
As noticed by Tong et al.38, Park et al.13 and other studies, some EBOV isolates contain 
clusters of T-to-C mutations within relatively short stretches of the genome. Interferon-
inducible adenosine deaminases acting on RNA (ADAR) are known to induce adenosine to 
inosine hypermutations in double-stranded RNA42. ADARs have been suggested to act on 
RNAs from numerous groups of viruses43. When negative sense single stranded RNA virus 
genomes are edited by ADARs, A-to-G hypermutations seem to preferentially occur on the 
negative strand, which results in U/T-to-C mutations on the positive strand44–46. Multiple T-
to-C mutations are introduced simultaneously via ADAR-mediated RNA editing which 
would interfere with molecular clock estimates and, by extension, the tree topology. We thus 
designate four or more T-to-C mutations within 300 nucleotides of each other as a putative 
hypermutation tract, whenever there is evidence that all T-to-C mutations within such 
stretches were introduced at the same time, i.e. every T-to-C mutation in a stretch occurred 
on a single branch. We detect a total of 15 hypermutation patterns with up to 13 T-to-C 
mutations within 35 to 145 nucleotides. Of these patterns, 11 are unique to a single genome 
and 4 are shared across multiple isolates, suggesting that occasionally viruses survive 
hypermutation are transmitted47. Putative tracts of T-to-C hypermutation almost exclusively 
occur within non-coding intergenic regions, where their effects on viral fitness are 
presumably minimal. In each case we mask out these sites as ambiguous nucleotides but 
leave the first T-to-C mutation unmasked to provide phylogenetic information on the 
relatedness of these sequences.
Phylogenetic inference
Molecular evolution was modelled according to a HKY+Γ448, 49 substitution model 
independently across four partitions (codon positions 1, 2, 3 and non-coding intergenic 
regions). Site-specific rates were scaled by relative rates in the four partitions. Evolutionary 
rates were allowed to vary across the tree according to a relaxed molecular clock that draws 
branch-specific rates from a log-normal distribution50. A non-parametric coalescent 
‘Skygrid’ model was used to act as a prior density across trees51. The overall evolutionary 
rate was given an uninformative continuous-time Markov chain (CTMC) reference prior52, 
while the rate multipliers for each partition were given an uninformative uniform prior over 
their bounds. All other priors used to infer the phylogenetic tree were left at their default 
values. BEAST XML files are available from https://github/ebov/space-time/data/. We ran 
an additional analysis with a subset of data (787 sequences collected up to November 2014 
— the peak of case numbers in Sierra Leone) to test the robustness of inference if they had 
been performed mid-epidemic.
Geographic history reconstruction
The level of administrative regions within each country was chosen so that population sizes 
between regions are comparable. For each country the appropriate administrative regions 
were: prefecture for Guinea (administrative subdivision level 2), county for Liberia (level 1) 
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and district for Sierra Leone (level 2). We refer to them as regions (63 in total but only 56 
are recorded to have had EVD cases) and each sequence, where available, was assigned the 
region where the patient was recorded to have been infected as a discrete trait. When the 
region within a country was unknown (N=223), we inferred the sequence location as a latent 
variable with equal prior probability over all available regions within that country. Most of 
the sequences with unknown regional origins were from Sierra Leone (N=151), followed by 
Liberia (N=69) and Guinea (N=3). In the absence of any geographic information (N=2) we 
inferred both the country and the region of a sequence.
We deploy an asymmetric continuous-time Markov chain (CTMC)53, 54 matrix to infer 
instantaneous transitions between regions. For 56 regions with recorded EVD cases, a total 
of 3080 independent transition rates would be challenging to infer from one realisation of 
the process, even when reduced to a sparse migration matrix using stochastic search variable 
selection (SSVS)53.
Thus, to infer the spatial phylogenetic diffusion history between the K = 56 locations, we 
adopt a sparse generalized linear model (GLM) formulation of continuous-time Markov 
chain (CTMC) diffusion16. This model parameterizes the instantaneous movement rate Λij 
from location i to location j as a log-linear function of P potential predictors Xij = (xij1, …, 
xijP)′ with unknown coefficients β = (β1, …, βP)′ and diagonal matrix δ with entries (δ1, 
…, δP). These latter unknown indicators δp ∈ {0, 1} determine predictor p’s inclusion in or 
exclusion from the model. We generalize this formulation here to include two-way random 
effects that allow for location origin- and destination-specific variability. Our two-way 
random effects GLM becomes
(1)
where ε = (ε1, …, εK) are the location-specific effects. These random effects account for 
unexplained variability in the diffusion process that may otherwise lead to spurious inclusion 
of predictors.
We follow16 in specifying that a priori all βp are independent and normally distributed with 
mean 0 and a relatively large variance of 4 and in assigning independent Bernoulli prior 
probability distributions on δp.
Let q be the inclusion probability and w be the probability of no predictors being included. 
Then, using the distribution function of a binomial random variable q = 1 − w1/P, where P is 
the number of predictors, as before. We use a small success probability on each predictor’s 
inclusion that reflects a 50% prior probability (w) on no predictors being included.
In our main analysis, we consider 25 individual predictors that can be classified as 
geographic, administrative, demographic, cultural and climatic covariates of spatial spread 
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(Table 3). Where measures are region-specific (rather than pairwise region measures), we 
specify both an origin and destination predictor. We also tested for sampling bias by 
including an additional origin and destination predictor based on the residuals for the 
regression of sample size against case count (cfr. Figure 1b), but these predictors did not 
receive any support (data not shown).
To draw posterior inference, we follow16 in integrating β and δ, and further employ a 
random-walk Metropolis transition kernel on ε and sample σ2 directly from its full 
conditional distribution using Gibbs sampling.
To obtain a joint posterior estimate from this joint genetic and phylogeographic model, an 
MCMC chain was run in BEAST 1.8.455 for 100 million states, sampling every 10 000 
states. The first 1000 samples in each chain were removed as burnin, and the remaining 9 
000 samples used to estimate a maximum clade credibility tree and to estimate posterior 
densities for individual parameters. A second independent run of 100 million states was 
performed to check convergence of the first.
To consider the feasibility of ‘real-time’ inference from virus genome data from the height 
of the EVD epidemic we took only those sequences derived from samples taken up until the 
end of October 2014 (N = 787). We undertook the same joint phylogenetic and spatial GLM 
analysis as for the full data set including the same set of 25 predictors. We ran this analysis 
for 200 million states, sampling every 20,000 states and removing the first 10% of samples.
To obtain realisations of the phylogenetic CTMC process, including both transitions 
(Markov jumps) between states and waiting times (Markov rewards) within states, we 
employ posterior inference of the complete Markov jump history through time16, 56. In 
addition to transitions ‘within’ the phylogeny, we also estimate the expected number of 
transitions ‘from’ origin location i in the phylogeographic tree to arbitrary ‘destination’ 
location j as follows:
(2)
where τi is the waiting time (or Markov reward) in ‘origin’ state i throughout the phylogeny, 
μ is the overall rate scalar of the location transition process, πi is the equilibrium frequency 
of ‘origin’ state i, and c is the normalising constant applied to the CTMC rate matrices in 
BEAST. To obtain the expected number of transitions to a particular destination location 
from any phylogeographic location (integrating over all possible locations across the 
phylogeny), we sum over all 56 origin locations included in the analysis. We note that the 
destination location can also be a location that was not included in the analysis because we 
only need to consider destination j in the instantaneous movement rates Λij; since the log of 
these rates are parameterized as a log linear function of the predictors, we can obtain these 
rates through the coefficient estimates from the analysis and the predictors extended to 
include these additional locations. Specifically, we use this to predict introductions in 
regions in Guinea, for which no cases were reported (n = 7) and for regions in neighbouring 
countries along the borders with Guinea or Liberia that remained disease free (n = 18). To 
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obtain such estimates under different predictors or predictor combinations, we perform a 
specific analysis under the GLM model including only the relevant predictors or predictor 
combinations without the two-way random effects. For computational expedience, we 
performed these analyses, as well as the time-inhomogeneous analyses below, by 
conditioning on a set of 1,000 trees from the posterior distribution of the main phylogenetic 
analysis16. We summarize mean posterior estimates for the transition expectations based on 
the samples obtained by our MCMC analysis; we note that also the value of c is sample-
specific.
Time-dependent spatial diffusion
To consider time-inhomogeneity in the spatial diffusion process, we start by borrowing 
epoch modelling concepts from Bielejec et al. (2014)57. The epoch GLM parameterizes the 
instantaneous movement rate Λijt from state i to state j within epoch t as a log-linear 
function of P epoch-specific predictors Xijt = (xijt1, …, xijtP)′ with constant-through-time, 
unknown coefficients β. We generalize this model to incorporate time-varying contribution 
of the predictors through time-varying coefficients β(t) using a series of change-point 
processes. Specifically, the time-varying epoch GLM models
(3)
where βB = (βB1, …, βBP)′ are the unknown coefficients before the change-points, βA = 
(βA1, …, βAP)′ are the unknown coefficients after the change-points, diagonal matrix ϕ(t) 
has entries (1t>t1(t), …, 1t>tP(t)), 1(·)(t) is the indicator function and T = (t1, …, tP) are the 
unknown change-point times. In this general form, the contribution of predictor p before its 
change-point time tp is βBp and its contribution after is βAp for p = 1, …, P. Fixing tp to be 
less than the time of the first epoch or greater than the time of the last epoch results in a 
time-invariant coefficient for that predictor.
Similar to the constant-through-time GLM, we specify that a priori all βBp and βAp are 
independent and normally distributed with mean 0 and a relatively large variance of 4. Under 
the prior, each tp is equally likely to lie before any epoch.
We employ random-walk Metropolis transition kernels on βB, βA and T.
In a first epoch GLM analysis, we keep the five predictors that are convincingly supported 
by the time-homogeneous analysis included in the model and estimate an independent 
change-point tp for their associated effect sizes: distance (tdis), within country effect (twco), 
shared international border (tsib) and origin and destination population size (tpopo and tpopd) 
change-points. To quantify the evidence in favour of each change-point, we calculate Bayes 
factor support based on the prior and posterior odds that tp is less than the time of the first 
epoch or greater than the time of the last epoch. Because we find only very strong support 
for a change-point in the within country effect, we subsequently estimate the effect sizes 
before and after twco, keeping the remaining four predictors homogeneous through time.
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Within-location generalized linear models
Ebola virus disease (EVD) case numbers are reported by the WHO for every country 
division (region) at the appropriate administrative level, split by epidemiological week. For 
every region and for each epidemiological week four numbers are reported: new cases in the 
patient and situation report databases as well as whether the new cases are confirmed or 
probable. At the height of the epidemic many cases went unconfirmed, even though they 
were likely to have been genuine EVD. As such, we treat probable EVD cases in WHO 
reports as confirmed and combine them with lab-confirmed EVD case numbers. Following 
this we take the higher combined case number of situation report and patient databases. The 
latest situation report in our data goes up to the epidemiological week spanning 8 to 14 
February 2016, with all case numbers being downloaded on 22 February 2016. There are 
apparent discrepancies between cumulative case numbers reported for each country over the 
entire epidemic and case numbers reported per administrative division over time, such that 
our estimate for the final size of the epidemic, based on case numbers over time reported by 
the WHO, is on the order of 22 000 confirmed and suspected cases of EVD compared to the 
official estimate of around 28 000 cases across the entire epidemic. This likely arose because 
case numbers are easier to track at the country level, but become more difficult to narrow 
down to administrative subdivision level, especially over time (only 86% of the genome 
sequence have known location of infection).
We studied the association between disease case counts using generalized linear models in a 
very similar fashion to the framework presented above. A list of the location-level predictors 
we used for these analyses can be found in Table 3. We also employed SSVS as described 
above, in order to compute Bayes factors (BF) for each predictor. In keeping with the genetic 
GLM analyses, we also set the prior inclusion probabilities such that there was a 50% 
probability of no predictors being included.
where r is the over-dispersion parameter, δi are the indicators as before. Prior distributions 
on model parameters for these analyses were the same as those used for the genetic analyses 
whenever possible. We then employed this model to predict how many cases the locations 
which reported zero EVD cases would have gathered, that is, the potential size of the 
epidemic in each location.
Computational details
To fit the models described above we took advantage of the routines already built in BEAST 
(https://github.com/beast-dev/beast-mcmc) but in a non-phylogenetic setting. Once again, 
posterior distributions for the parameters were explored using Markov chain Monte Carlo 
(MCMC). We ran each chain for 50 million iterations and discarded at least 10% of the 
samples as burn-in. Convergence was checked by visual inspection of the chains and 
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checking that all parameters had effective sample sizes (ESS) greater than 200. We ran 
multiple chains to ensure results were consistent. To make predictions, we used 50,000 
Monte Carlo samples from the posterior distribution of coefficients and the overdispersion 
parameter (r) to simulate case counts for all locations with zero recorded EVD cases.
Data availability
All collated data, genetic sequence alignments, phylogenetic trees, analysis scripts, and 
analysis output are available at https://github.com/ebov/space-time) and http://dx.doi.org/
10.7488/ds/1711. Individual virus genetic sequences are published in earlier works and are 
available from NCBI Genbank.
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Figure 1. Distribution and correlation of EVD cases and EBOV sequences
a) Administrative regions within Guinea (green), Sierra Leone (blue) and Liberia (red); 
shading is proportional to the cumulative number of known and suspected EVD cases in 
each region. Darkest shades represent 784 cases for Guinea (Macenta Prefecture), 3219 
cases for Sierra Leone (Western Area Urban District) and 2925 cases for Liberia 
(Montserrado County); hatching indicate regions without reported EVD cases. Circle 
diameters are proportional to the number of EBOV genomes available from that region over 
the entire EVD epidemic with the largest representing 152 sequences. Crosses mark regions 
for which no sequences are available. Circles and crosses are positioned at population 
centroids within each region. b) A plot of number of EBOV genomes sampled against the 
known and suspected cumulative EVD case numbers. Regions in Guinea are denoted in 
green, Sierra Leone in blue and Liberia in red. Spearman correlation coefficient: 0.93.
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Figure 2. Summary of early epidemic events
a) Temporal phylogeny of earliest sampled EBOV lineages in Guéckédou Prefecture, 
Guinea. 95% posterior densities of most recent common ancestor estimates for all lineages 
(grey) and lineages into Kailahun District, Sierra Leone (blue) and to Conakry Prefecture, 
Guinea (green) are shown at the bottom. Posterior probabilities > 0.5 are shown for lineages 
with >5 descendent sequences). b) Dispersal events marked by dashed lineages on the 
phylogeny projected on a map with directionality indicated by colour intensity (from white 
to red). Lineages that migrated to Conakry Prefecture and Kailahun District have led to the 
vast majority of EVD cases throughout the region.
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Figure 3. Dispersal of virus lineages over time
Virus dispersal between administrative regions estimated under the GLM phylogeography 
model (see Supplementary Methods). The arcs are between population centroids of each 
region, show directionality from thin end to thick end and are coloured in a scale denoting 
time from December 2013 in blue to October 2015 in yellow. Countries are coloured with 
Liberia in red, Guinea in green and Sierra Leone in blue.
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Figure 4. Transmission chains arising from independent international movements
a) EBOV lineages by country (Guinea, green; Sierra Leone, blue; Liberia, red), tracked until 
the sampling date of their last known descendants. Circles at the roots of each subtree denote 
the country of origin for the introduced lineage. b) Estimates of the change point probability 
(primary Y-axis) and log coefficient (mean and credible interval; secondary Y-axis) for the 
Nat/Int factor. Vertical lines represent dates of border closures by the respective countries.
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Figure 5. Inference of GLM predictors in a ‘real-time’ context
For the data set constructed from EBOV genome sequences derived from samples taken up 
until October 2014 (blue), the same 5 spatial EBOV movement predictors were given 
categorical support (inclusion probabilities = 1.0) as for the full data set (red). Likewise, the 
coefficients for these predictors are consistent in their sign and magnitude.
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Figure 6. The effect of borders on EBOV migration rates between regions
Posterior densities of the migration rates between locations that share a geographical border 
(left) and those that do not (right) for international migrations and national migrations. 
Where two regions share a border, national migrations are only marginally more frequent 
than international migrations showing that both types of borders are porous to short local 
movement. Where the two regions are not adjacent, international migrations are much rarer 
than national migrations.
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Figure 7. Summarized epidemic international migration history
All viral movement events between countries (Guinea, green; Sierra Leone, blue; Liberia, 
red) are shown split by whether they are between a) geographically distant regions or b) 
regions that share the international border. Curved lines indicate median (intermediate colour 
intensity), and 95% highest posterior density intervals (lightest and darkest colour 
intensities) for the number of migrations that are inferred to have taken place between 
countries.
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Figure 8. Predicted destinations and consequences of viral dispersal
a) Predicted number of EBOV imports into each of 63 regions in Guinea, Sierra Leone and 
Liberia (including 7 without recorded cases in Guinea) and the surrounding 18 regions of the 
neighbouring countries of Guinea-Bissau, Senegal, Mali and Côte d’Ivoire. The expected 
number of EBOV exports from locations in the phylogeographic tree and imports to any 
location were calculated based on the phylogeographic GLM model estimates and associated 
predictors that were extended to apparently EVD-free locations (see Methods). b) Predicted 
EVD cluster sizes from the generalized linear model fitted to case data.
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Figure 9. Comparison of predicted and observed numbers of introductions (a) and case numbers 
(b)
Scatter plots on the left of both panels show inferred introduction numbers (a) or observed 
case numbers (b), coloured by region as in Figure 4. Administrative regions not reporting 
any cases are indicated with empty circles on the scatter plot. Administrative regions in the 
map on the right side of both panels are coloured by the residuals (as observed/predicted) of 
the scatter plot. Regions are coloured grey where 0.5<observed/predicted<2.0 and transition 
into red or blue colours for overestimation or underestimation, respectively.
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Figure 10. Region specific introductions, cluster sizes and persistence
Each row summarises independent introductions and the sizes (as numbers of sequences) of 
resulting outbreak clusters. Clusters are coloured by their inferred region of origin (colours 
same as Figure 4). The horizontal lines represent the persistence of each cluster from the 
time of introduction to the last sampled case (individual tips have persistence 0). The areas 
of the circles in the middle of the lines are proportional to the number of sequenced cases in 
the cluster. The areas of the circles next to the labels on the left represent the population 
sizes of each administrative region. Vertical lines within each cell indicate the dates of 
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declared border closures by each of the three countries: 11 June 2014 in Sierra Leone (blue), 
27 July 2014 in Liberia (red), and 09 August 2014 in Guinea (green).
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Figure 11. The metapopulation structure of the epidemic
a) Kernel density estimate (KDE) of distance for all inferred EBOV dispersals events: 50% 
occur over distances <72 km and <5% occur over distances >232 km. b) KDE of the number 
of independent EBOV introductions into each administrative region: 50% have fewer than 
4.8 and <5% greater than 21.3. c) KDE of the mean size of sampled cases resulting from 
each introduction with at least 2 sampled cases: 50% < 5.3, 95% <32. d) KDE of the 
persistence of clusters in days (from time of introduction to time of the last sampled case): 
50% < 36 days, 95% < 181 days.
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Figure 12. 
Kernel density estimates for inferred epidemiological statistics (from top to bottom): 
distance travelled (distance between population centroids, in kilometres), number of 
introductions that each location experienced, cluster size (number of sequences collected in 
a location as a result of a single introduction), cluster persistence (days from the common 
ancestor of a cluster to its last descendent, single tips have persistence of 0). Left hand side 
tracks these statistics for Sierra Leone (blue), Liberia (red) and Guinea (green), whilst the 
right hand side compares the statistics for before October 2014 (grey) and after (orange). 
Points with vertical lines connected to the x axis indicate the 50% and 95% quantiles of the 
parameter density estimates. Within Sierra Leone, Liberia and Guinea, 50% of all migrations 
occurred over distances of around 100km and persisted for around 25 days. Exceptions were 
Sierra Leone which experienced more introductions per location (around 12) than Guinea 
and Liberia (around 4) and Guinea, where migrations tended to occur over larger distances 
due to the size of the country and whose cluster sizes following introductions tended to be 
lower (3 sequences versus Liberia and Sierra Leone with 5 sequences each). Between the 
first (grey) and second (orange) years of the epidemic there were considerable reductions in 
cluster persistence, cluster sizes and distances travelled by viruses, whilst dispersal intensity 
remained largely the same.
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Figure 13. Relationship of cluster size, introductions and persistence to population size
a) The mean number of introductions into each location against (log) population sizes. The 
Western Area (in Sierra Leone) received the most introductions, whilst Conakry (in Guinea) 
and Montserrado (in Liberia) were closer to the average. The association between population 
sizes and number of introductions was not very strong (R2 = 0.28, pearson correlation = 
0.54, Spearman correlation = 0.57). b) The mean cluster size for each location plotted 
against (log) population sizes. The association here is weaker (R2 = 0.11, pearson correlation 
= 0.35, Spearman correlation = 0.57). c) The mean persistence times (per cluster, in days) 
against population sizes. A similarly weak association is observed (R2 = 0.12, pearson 
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correlation = 0.37, Spearman correlation = 0.36). All computations based on a sample of 
10,000 trees from the posterior distribution.
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Table 3
Predictors included in the time-homogenous GLM.
Predictor type Abbreviation Predictor description
Geographic Distances Great circle distances between the locations’ population centroids, log-transformed, standardized
Administrative Nat/Int The relative preference of transitioning between locations in the same country over transitioning 
between locations in two different countries
Administrative IntBoSh The relative preference of transitioning between location pairs that are in different countries and share 
a border
Administrative NatBoSh The relative preference of transitioning between location pairs that are in the same country and share a 
border
Administrative LibGinAsym Between Liberia-Guinea asymmetry
Administrative LibSLeAsym Between Liberia-Sierra Leone asymmetry
Administrative GinSLeAsym Between Guinea-Sierra Leone asymmetry
Demographic OrPop Origin population size, log-transformed, standardized
Demographic DestPop Destination population size, log-transformed, standardized
Demographic OrPopDens Origin population density, log-transformed, standardized
Demographic DestPopDens Destination population density, log-transformed, standardized
Demographic orTT100k Estimated mean travel time in minutes to reach the nearest major settlement of at least 100,000 people 
at origin, log-transformed, standardized
Demographic destinationTT100k estimated mean travel time in minutes to reach the nearest major settlement of at least 100,000 people 
at destination, log-transformed, standardized
Demographic OrGrEcon Origin Gridded economic output, log-transformed, standardized
Demographic DestGrEcon Destination Gridded economic output, log-transformed, standardized
Cultural IntLangShared The relative preference of transitioning between location pairs that are in different countries and share 
at least one of 17 vernacular languages
Cultural NatLangShared The relative preference of transitioning between location pairs that are in the same country and share 
at least one of 17 vernacular languages
Climatic OrTemp Temperature annual mean at origin, log-transformed, standardized
Climatic DestTemp Temperature annual mean at destination, log-transformed, standardized
Climatic OrTempSS Index of temperature seasonality at origin, log-transformed, standardized
Climatic DestTempSS Index of temperature seasonality at destination, log-transformed, standardized
Climatic OrPrecip Precipitation annual mean at origin, log-transformed, standardized
Climatic DestPrecip Precipitation annual mean at destination, log-transformed, standardized
Climatic OrPrecipSS Index of precipitation seasonality at origin, log-transformed, standardized
Climatic DestPrecipSS Index of precipitation seasonality at destination, log-transformed, standardized
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